Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
about
Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategiesThe emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.The relationships between snail1 and estrogen receptor signaling in breast cancer cells.Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.
P2860
Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
@en
Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
@nl
type
label
Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
@en
Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
@nl
prefLabel
Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
@en
Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
@nl
P2860
P356
P1476
Simultaneous targeting of estrogen receptor and HER2 in breast cancer.
@en
P2093
Hatem A Azim
Martine J Piccart
P2860
P304
P356
10.1586/ERA.10.99
P577
2010-08-01T00:00:00Z